Cytox Company
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer's Disease.
Investors
Technology:
AgeTech Companies
Industry:
Clinical Development, Deep diagnostics
Headquarters:
Manchester, Manchester, United Kingdom
Founded Date:
2004-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
16
Total Funding:
15484781
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019-01-01
Last Funding Type:
Grant
Register and Claim Ownership